Clincosm LogoSign in Get a demo

HIV-1-infection

Showing NaN - NaN of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV-1-infection Trial in United States (GS-5894, B/F/TAF, Standard of Care)

Recruiting
  • HIV-1-infection
  • Los Angeles, California
  • +15 more
Jan 13, 2023

HIV-1-infection Trial in Puerto Rico, United States (TMB-365/TMB-380)

Recruiting
  • HIV-1-infection
  • San Francisco, California
  • +6 more
Oct 25, 2022

HIV-1-infection Trial in Worldwide (Oral Lenacapavir, Oral Lenacapavir Placebo, Subcutaneous Lenacapavir)

Active, not recruiting
Has Results
  • HIV-1-infection
  • Oral Lenacapavir
  • +4 more
  • Los Angeles, California
  • +74 more
Oct 17, 2022

The Visceral Adiposity Measurement and Observation Study

Recruiting
  • HIV
  • +18 more
  • Diagnostic Test
  • HIV Anti-retroviral Background Therapy
  • Los Angeles, California
  • +5 more
Sep 21, 2022

HIV-1-infection Trial (Fostemsavir 600 MG [Rukobia])

Recruiting
  • HIV-1-infection
  • Fostemsavir 600 MG [Rukobia]
  • Orlando, Florida
    Orlando Immunology Center
Sep 20, 2022

HIV-1-infection Trial in United States (ibalizumab-uiyk)

Recruiting
  • HIV-1-infection
  • Los Angeles, California
  • +3 more
Dec 22, 2021

HIV-1-infection Trial in Worldwide (B/F/TAF, F/TAF, DTG)

Completed
Has Results
  • HIV-1-infection
  • Phoenix, Arizona
  • +93 more
Dec 14, 2021

HIV-1-infection Trial in Puerto Rico, United States (TMB-365)

Completed
  • HIV-1-infection
  • TMB-365
  • San Francisco, California
  • +5 more
Oct 5, 2021

HIV-1-infection Trial in United States (Albuvirtide, 3BNC117, Baseline ART)

Recruiting
  • HIV-1-infection
  • Palm Springs, California
  • +6 more
Sep 28, 2021

HIV-1-infection Trial in United States (There are no disallowed treatments)

Enrolling by invitation
  • HIV-1-infection
  • There are no disallowed treatments
  • San Francisco, California
  • +3 more
Jul 27, 2021